Birgitta Henriques Normark is a Swedish doctor and researcher, focusing on the field of host-bacteria interactions and pneumococcal infections. She is a professor of Clinical Microbiology at the Karolinska Institute and is the head physician at the Karolinska University Hospital. She is a member of a number of academies including the European Academy of Microbiology, the American Academy of Microbiology, and the Royal Swedish Academy of Sciences, of which she was elected president in 2022.
As a physician, Henriques-Normark worked at the Swedish Institute for Infectious Disease Control, where she became the department head. [1] In 2008, Henriques-Normark became a professor in the field of medical microbial pathogenesis, and then in 2011, was appointed to a joint position as a professor of Clinical Microbiology at the Karolinska Institute and Head Physician at the Karolinska University Hospital, in the department of Microbiology, Tumour and Cell Biology. [1] In the same year, she was awarded a grant from the Knut and Alice Wallenberg Foundation to study pneumococcal infections, which amounts to 25.8 million SEK over 5 years. [2]
She is an elected member or fellow of a number of academic societies: in 2013, she was elected fellow of the European Academy of Microbiology, [1] in 2015 as a fellow of the American Academy of Microbiology, [3] [1] in 2018 as a member of the Swedish Royal Academy of Sciences, [4] and in 2019 both as a member of the European Molecular Biology Organisation [5] and as a member of the Nobel Assembly at the Karolinska Institute, which awards the Nobel Prize. [6] In 2022, she was elected president of the Swedish Royal Academy of Sciences. [4]
She has fulfilled a number of key roles at the Karolinska Institute. She was the Vice Dean for Recruitment for 6 years, the Academic Vice President for Research, [1] and Chairman of the Committee for Research. [4] Outside of the KI, she has evaluated research for the ERC and the EU commission, [1] is a member of a steering board for medicine and health at the Swedish Research Council, [1] and is a member of the European Academy of Microbiology Executive Board. [3]
Birgitta Henriques Normark is a Swedish doctor and researcher, focusing on the field of host-bacteria interactions and pneumococcal infections. She is a professor of Clinical Microbiology at the Karolinska Institute and is the head physician at the Karolinska University Hospital. She is a member of a number of academies including the European Academy of Microbiology, the American Academy of Microbiology, and the Royal Swedish Academy of Sciences, of which she was elected president in 2022.
As a physician, Henriques-Normark worked at the Swedish Institute for Infectious Disease Control, where she became the department head. [1] In 2008, Henriques-Normark became a professor in the field of medical microbial pathogenesis, and then in 2011, was appointed to a joint position as a professor of Clinical Microbiology at the Karolinska Institute and Head Physician at the Karolinska University Hospital, in the department of Microbiology, Tumour and Cell Biology. [1] In the same year, she was awarded a grant from the Knut and Alice Wallenberg Foundation to study pneumococcal infections, which amounts to 25.8 million SEK over 5 years. [2]
She is an elected member or fellow of a number of academic societies: in 2013, she was elected fellow of the European Academy of Microbiology, [1] in 2015 as a fellow of the American Academy of Microbiology, [3] [1] in 2018 as a member of the Swedish Royal Academy of Sciences, [4] and in 2019 both as a member of the European Molecular Biology Organisation [5] and as a member of the Nobel Assembly at the Karolinska Institute, which awards the Nobel Prize. [6] In 2022, she was elected president of the Swedish Royal Academy of Sciences. [4]
She has fulfilled a number of key roles at the Karolinska Institute. She was the Vice Dean for Recruitment for 6 years, the Academic Vice President for Research, [1] and Chairman of the Committee for Research. [4] Outside of the KI, she has evaluated research for the ERC and the EU commission, [1] is a member of a steering board for medicine and health at the Swedish Research Council, [1] and is a member of the European Academy of Microbiology Executive Board. [3]